Cargando…
Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
BACKGROUND & AIMS: The albumin-bilirubin (ALBI) score is calculated using serum levels of total bilirubin and albumin as a simple method to assess liver function. This study investigated the ability of baseline ALBI score/grade measurements to assess histological stage and disease progression in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976453/ https://www.ncbi.nlm.nih.gov/pubmed/36873419 http://dx.doi.org/10.1016/j.jhepr.2022.100662 |
_version_ | 1784899079536377856 |
---|---|
author | Yamashita, Yuki Umemura, Takeji Kimura, Takefumi Joshita, Satoru Hirohara, Junko Nakano, Toshiaki Komori, Atsumasa Tanaka, Atsushi |
author_facet | Yamashita, Yuki Umemura, Takeji Kimura, Takefumi Joshita, Satoru Hirohara, Junko Nakano, Toshiaki Komori, Atsumasa Tanaka, Atsushi |
author_sort | Yamashita, Yuki |
collection | PubMed |
description | BACKGROUND & AIMS: The albumin-bilirubin (ALBI) score is calculated using serum levels of total bilirubin and albumin as a simple method to assess liver function. This study investigated the ability of baseline ALBI score/grade measurements to assess histological stage and disease progression in individuals with primary biliary cholangitis (PBC) in a large Japanese nationwide cohort. METHODS: A total of 8,768 Japanese patients with PBC were enrolled between 1980 and 2016 from 469 institutions, among whom 83% received ursodeoxycholic acid (UDCA) only, 9% received UDCA and bezafibrate, and 8% were given neither drug. Baseline clinical and laboratory parameters were retrospectively retrieved and reviewed from a central database. Associations of ALBI score/grade with histological stage, mortality, and need for liver transplantation (LT) were evaluated using Cox proportional hazards models. RESULTS: During the median follow-up period of 5.3 years, 1,227 patients died (including 789 from liver-related causes) and 113 underwent LT. ALBI score and ALBI grade were significantly associated with Scheuer’s classification (both p <0.0001). ALBI grade 2 or 3 had significant associations with all-cause mortality or need for LT as well as liver-related mortality or need for LT according to Cox proportional hazards regression analysis (hazard ratio 3.453, 95% CI 2.942–4.052 and hazard ratio 4.242, 95% CI 3.421–5.260, respectively; both p <0.0001). Cumulative LT-free survival rates at 5 years in the ALBI grade 1, 2, and 3 groups were 97.2%, 82.4%, and 38.8%, respectively, while respective non-liver-related survival rates were 98.1%, 86.0%, and 42.0% (both p <0.0001, log-rank test). CONCLUSIONS: This large nationwide study of patients with PBC suggested that baseline measurements of ALBI grade were a simple non-invasive predictor of prognosis in PBC. IMPACT AND IMPLICATIONS: Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts. This study examined the ability of albumin-bilirubin (ALBI) score/grade to estimate histological findings and disease progression in PBC by means of a large-scale nationwide cohort in Japan. ALBI score/grade were significantly associated with Scheuer’s classification stage. Baseline ALBI grade measurements may be a simple non-invasive predictor of prognosis in PBC. |
format | Online Article Text |
id | pubmed-9976453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99764532023-03-02 Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis Yamashita, Yuki Umemura, Takeji Kimura, Takefumi Joshita, Satoru Hirohara, Junko Nakano, Toshiaki Komori, Atsumasa Tanaka, Atsushi JHEP Rep Research Article BACKGROUND & AIMS: The albumin-bilirubin (ALBI) score is calculated using serum levels of total bilirubin and albumin as a simple method to assess liver function. This study investigated the ability of baseline ALBI score/grade measurements to assess histological stage and disease progression in individuals with primary biliary cholangitis (PBC) in a large Japanese nationwide cohort. METHODS: A total of 8,768 Japanese patients with PBC were enrolled between 1980 and 2016 from 469 institutions, among whom 83% received ursodeoxycholic acid (UDCA) only, 9% received UDCA and bezafibrate, and 8% were given neither drug. Baseline clinical and laboratory parameters were retrospectively retrieved and reviewed from a central database. Associations of ALBI score/grade with histological stage, mortality, and need for liver transplantation (LT) were evaluated using Cox proportional hazards models. RESULTS: During the median follow-up period of 5.3 years, 1,227 patients died (including 789 from liver-related causes) and 113 underwent LT. ALBI score and ALBI grade were significantly associated with Scheuer’s classification (both p <0.0001). ALBI grade 2 or 3 had significant associations with all-cause mortality or need for LT as well as liver-related mortality or need for LT according to Cox proportional hazards regression analysis (hazard ratio 3.453, 95% CI 2.942–4.052 and hazard ratio 4.242, 95% CI 3.421–5.260, respectively; both p <0.0001). Cumulative LT-free survival rates at 5 years in the ALBI grade 1, 2, and 3 groups were 97.2%, 82.4%, and 38.8%, respectively, while respective non-liver-related survival rates were 98.1%, 86.0%, and 42.0% (both p <0.0001, log-rank test). CONCLUSIONS: This large nationwide study of patients with PBC suggested that baseline measurements of ALBI grade were a simple non-invasive predictor of prognosis in PBC. IMPACT AND IMPLICATIONS: Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts. This study examined the ability of albumin-bilirubin (ALBI) score/grade to estimate histological findings and disease progression in PBC by means of a large-scale nationwide cohort in Japan. ALBI score/grade were significantly associated with Scheuer’s classification stage. Baseline ALBI grade measurements may be a simple non-invasive predictor of prognosis in PBC. Elsevier 2022-12-24 /pmc/articles/PMC9976453/ /pubmed/36873419 http://dx.doi.org/10.1016/j.jhepr.2022.100662 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Yamashita, Yuki Umemura, Takeji Kimura, Takefumi Joshita, Satoru Hirohara, Junko Nakano, Toshiaki Komori, Atsumasa Tanaka, Atsushi Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis |
title | Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis |
title_full | Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis |
title_fullStr | Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis |
title_full_unstemmed | Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis |
title_short | Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis |
title_sort | prognostic utility of albumin-bilirubin grade in japanese patients with primary biliary cholangitis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976453/ https://www.ncbi.nlm.nih.gov/pubmed/36873419 http://dx.doi.org/10.1016/j.jhepr.2022.100662 |
work_keys_str_mv | AT yamashitayuki prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis AT umemuratakeji prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis AT kimuratakefumi prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis AT joshitasatoru prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis AT hiroharajunko prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis AT nakanotoshiaki prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis AT komoriatsumasa prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis AT tanakaatsushi prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis |